Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (30)

2023

  1. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. Multimodal Physical Exercise and Functional Rehabilitation Program in Oncological Patients with Cancer-Related Fatigue—A Randomized Clinical Trial

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 6

  4. Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2

    Reumatologia clinica, Vol. 19, Núm. 2, pp. 121

2022

  1. Adaptation and validation of the Spanish version of the everyday cognition battery for assessing everyday cognition in older adults

    BMC Geriatrics, Vol. 22, Núm. 1

  2. Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 266-269

  3. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  4. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

  5. Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer

    Oral Oncology, Vol. 134

2021

  1. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

    Reumatologia Clinica, Vol. 17, Núm. 10, pp. 559-561

  2. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  3. Head and neck cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1393-1401

  4. Immunotherapy in lung cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1424-1428

  5. Impact of a comprehensive functional rehabilitation programme on the quality of life of the oncological patient with dyspnoea

    Medicina Clinica, Vol. 157, Núm. 1, pp. 10-16

  6. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 764-772

  7. Mesothelioma

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1402-1408

  8. Molecular and cellular biomarkers. Implications for targeted therapy

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1418-1423

  9. Multimodal physical exercise and functional rehabilitation program in oncological patients with asthenia. study protocol

    BMC Nursing, Vol. 20, Núm. 1

  10. Non-small cell lung cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1377-1387

  11. Paciente gran superviviente con cáncer de cabeza y cuello metastásico y tratamiento con inmunoterapia

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1429.e1-1429.e3